scholarly article | Q13442814 |
P50 | author | Margaret A. Honein | Q25001578 |
P2093 | author name string | J D Erickson | |
T J Mathews | |||
L J Paulozzi | |||
L Y Wong | |||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | folic acid | Q127060 |
P304 | page(s) | 2981-6 | |
P577 | publication date | 2001-06-20 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects | |
P478 | volume | 285 |
Q36625015 | 2005 AES annual course: evidence used to treat women with epilepsy |
Q42368242 | A Cross-Sectional Study of Dietary and Genetic Predictors of Blood Folate Levels in Healthy Young Adults. |
Q24803710 | A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects |
Q57295979 | A folic acid-enriched diet attenuates prostate involution in response to androgen deprivation |
Q64115694 | A propensity-matched study of the association between optimal folic acid supplementation and birth defects in Shaanxi province, Northwestern China |
Q35012209 | A reproductive history of mothers with spina bifida offspring--a new look at old issues |
Q36741603 | A systematic review of dietary assessments of pregnant adolescents in industrialised countries. |
Q45017194 | Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan |
Q44594319 | Acute absorption of folic acid from a fortified low-fat spread. |
Q46475845 | Aleurone flour increases red-cell folate and lowers plasma homocyst(e)ine substantially in man. |
Q38794708 | An overview of folate status in a population-based study from São Paulo, Brazil and the potential impact of 10 years of national folic acid fortification policy |
Q79274572 | Antagonism of Hypervitaminosis A-Induced Anterior Neural Tube Closure Defects with a Methyl-Donor Deficiency in Murine Whole-Embryo Culture |
Q34905287 | Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest? |
Q44512476 | Application of stable isotope dilution assays based on liquid chromatography-tandem mass spectrometry for the assessment of folate bioavailability |
Q40290701 | Assessment of the potential effect of incremental increases in folic acid intake on neural tube defects in Australia and New Zealand. |
Q51998310 | Assistive technology use among adolescents and young adults with spina bifida. |
Q36108242 | Association Between Preconception Counseling and Folic Acid Supplementation Before Pregnancy and Reasons for Non-Use |
Q35772757 | Association of facilitated glucose transporter 2 gene variants with the myelomeningocele phenotype |
Q39294937 | Association of maternal homocysteine and vitamins status with the risk of neural tube defects in Tunisia: A case-control study |
Q44264110 | Association of neural tube defects and folic acid food fortification in Canada |
Q80760037 | Awareness and consumption of folate-fortified foods by women of childbearing age in Western Australia |
Q99604766 | B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease |
Q90076309 | Bacteria increase host micronutrient availability: mechanisms revealed by studies in C. elegans |
Q35615440 | Balancing benefits and harms in public health prevention programmes mandated by governments |
Q37968645 | Beyaz®: an oral contraceptive fortified with folate |
Q79274638 | Bioaccessibility of Folic Acid and (6S)-5-Methyltetrahydrofolate Decreases after the Addition of Folate-Binding Protein to Yogurt as Studied in a Dynamic In Vitro Gastrointestinal Model |
Q37235407 | Biological variability and impact of oral contraceptives on vitamins B(6), B(12) and folate status in women of reproductive age |
Q47319935 | Birth order and neural tube defects: a reappraisal |
Q36036103 | Birth prevalence of selected external structural birth defects at four hospitals in Dar es Salaam, Tanzania, 2011-2012 |
Q37003087 | Black-white differences in maternal age, maternal birth cohort, and period effects on infant mortality in the US (1983-2002). |
Q26865543 | Born too soon: care before and between pregnancy to prevent preterm births: from evidence to action |
Q21245277 | CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population |
Q51102176 | Can an electronic health record system be used for preconception health optimization? |
Q35110793 | Challenges and new opportunities for clinical nutrition interventions in the aged |
Q40482536 | Changes in knowledge and attitudes of folate, and use of dietary supplements among women of reproductive age in Norway 1998-2000. |
Q33515178 | Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins |
Q37149165 | Circulating folic acid in plasma: relation to folic acid fortification |
Q35147180 | Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation |
Q43719368 | Comparing nutrient intake from food to the estimated average requirements shows middle- to upper-income pregnant women lack iron and possibly magnesium |
Q24676916 | Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate |
Q97897386 | Comprehensive Vitamer Profiling of Folate Mono- and Polyglutamates in Baker's Yeast (Saccharomyces cerevisiae) as a Function of Different Sample Preparation Procedures |
Q35077898 | Congenital Malformations and Consequential Epidemiology. |
Q51759210 | Congenital abnormalities in newborns of women with pregestational diabetes: A time-trend analysis, 1994 to 2009. |
Q36595615 | Congenital malformations in Lubumbashi (Democratic Republic of Congo): about 72 cases observed and advocacy for the development of a National Registry of Congenital Malformations and a National Reference Center for Human Genetics |
Q43646372 | Consumption of Folic Acid–Fortified Bread Improves Folate Status in Women of Reproductive Age in Chile |
Q46084767 | Consumption of potentially fortifiable foods by women and young children varies by ecological zone and socio-economic status in Cameroon |
Q28083544 | Contemporary issues surrounding folic Acid fortification initiatives |
Q37409132 | Cross-sectional study of nutritional markers in pregnancy |
Q37795209 | Cultural Considerations in the Care of Children with Spina Bifida |
Q36938828 | DNA methylation impacts on learning and memory in aging |
Q84066438 | Decreased incidence of myelomeningocele at birth: effect of folic acid recommendations or prenatal diagnostics? |
Q44143241 | Decreasing prevalence of neural tube defects in Utah, 1985-2000. |
Q35891898 | Deep sequencing study of the MTHFR gene to identify variants associated with myelomeningocele |
Q35846818 | Descriptive epidemiology of selected birth defects, areas of Lombardy, Italy, 1999. |
Q41099350 | Descriptive study on neural tube defects in Argentina |
Q44485426 | Design and evaluation of interventions promoting periconceptional multivitamin use. |
Q50504909 | Determinants of folate status in pregnant women: results from a national cross-sectional survey in Belgium. |
Q36840717 | Determinants of increases in stillbirth rates from 2000 to 2010. |
Q37101821 | Determinants of neural tube defect (NTD)-protective circulating concentrations of folate in women of child-bearing age in the US post-folic acid fortification era |
Q33822673 | Developmental origins of health and disease: environmental exposures |
Q37351323 | Diabetes and apoptosis: neural crest cells and neural tube. |
Q34921415 | Diet and cancer prevention: the roles of observation and experimentation |
Q48890677 | Distress associated with prenatal screening for fetal abnormality |
Q33710228 | Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions |
Q36297515 | Dominant negative FADD dissipates the proapoptotic signalosome of the unfolded protein response in diabetic embryopathy. |
Q38730773 | Early Life Exposures and Adult Cancer Risk. |
Q35402500 | Economic burden of neural tube defects and impact of prevention with folic acid: a literature review |
Q39908471 | Effect of folic acid supplementation on cancer risk among adults with hypertension in China: A randomized clinical trial |
Q44701455 | Effect of increasing voluntary folic acid food fortification on dietary folate intakes and adequacy of reproductive-age women in New Zealand |
Q38382091 | Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes |
Q28578341 | Effect of prenatal exposure to ethanol on hepatic elongation factor-2 and proteome in 21 d old rats: protective effect of folic acid |
Q36732102 | Effectiveness of Folic Acid Fortified Flour for Prevention of Neural Tube Defects in a High Risk Region. |
Q44214432 | Effects of folic acid fortification on the prevalence of neural tube defects. |
Q44777677 | Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women |
Q34347947 | Effects of prenatal and/or postnatal (maternal and/or child) folic acid supplementation on the mental performance of children. |
Q46202671 | Efficacy of flour fortification with folic acid in women of childbearing age in Iran |
Q35231619 | Emergent care patterns in patients with spina bifida: a case-control study |
Q33431318 | Emerging treatments for retinopathy of prematurity |
Q28119135 | Enzymatic properties of ALDH1L2, a mitochondrial 10-formyltetrahydrofolate dehydrogenase |
Q35183469 | Epidemiology of neural tube defects in Saudi Arabia |
Q35183494 | Epidemiology, prenatal management, and prevention of neural tube defects. |
Q37246188 | Establishing safe and potentially efficacious fortification contents for folic acid and vitamin B12. |
Q33814179 | Estimating the burden of neural tube defects in low- and middle-income countries |
Q50092312 | Ethics of maternal vaccination |
Q35754318 | Evidence for suboptimal use of periconceptional folic acid supplements globally |
Q38132307 | Evidence-based preconceptional lifestyle interventions |
Q24655093 | Fetal surgery for neural tube defects |
Q92541392 | Fluorescence lateral flow competitive protein binding assay for the assessment of serum folate concentrations |
Q45130495 | Folate absorption from folate-fortified and processed foods using a human ileostomy model |
Q38024316 | Folate and breast cancer: what about high-risk women? |
Q38135226 | Folate and epigenetic mechanisms in neural tube development and defects |
Q37246124 | Folate and vitamin B12 metabolism: overview and interaction with riboflavin, vitamin B6, and polymorphisms |
Q36981798 | Folate and vitamin B12: friendly or enemy nutrients for the elderly |
Q33790582 | Folate bioavailability: implications for establishing dietary recommendations and optimizing status |
Q46074300 | Folate biofortification of lettuce by expression of a codon optimized chicken GTP cyclohydrolase I gene |
Q28302935 | Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects |
Q30387709 | Folate during reproduction: the Canadian experience with folic acid fortification. |
Q54753139 | Folate intake and MTHFR polymorphism C677T is not associated with ovarian cancer risk: evidence from the meta-analysis. |
Q47808810 | Folate is absorbed across the colon of adults: evidence from cecal infusion of (13)C-labeled [6S]-5-formyltetrahydrofolic acid. |
Q45262110 | Folate promotion in Western Australia and the prevention of neural tube defects |
Q57297425 | Folate promotion in Western Australia and the prevention of neural tube defects |
Q44217432 | Folate revisited |
Q35671164 | Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day. |
Q43275295 | Folate stimulates ERK1/2 phosphorylation and cell proliferation in fetal neural stem cells |
Q33660202 | Folate, DNA methylation, and mouse models of breast tumorigenesis |
Q35806733 | Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies |
Q35163357 | Folate, vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center |
Q82606741 | Folic Acid supplementation and pregnancy: more than just neural tube defect prevention |
Q85961243 | Folic acid and cancer--where are we today? |
Q35244421 | Folic acid and human reproduction-ten important issues for clinicians |
Q51158880 | Folic acid awareness and intake among women in areas with high prevalence of neural tube defects in China: a cross-sectional study. |
Q93092567 | Folic acid deficiency declined substantially after introduction of the mandatory fortification programme in Queensland, Australia: a secondary health data analysis |
Q35671211 | Folic acid food fortification-its history, effect, concerns, and future directions |
Q37246181 | Folic acid for the prevention of neural tube defects: the Danish experience |
Q39757475 | Folic acid fortification and prevalences of neural tube defects, orofacial clefts, and gastroschisis in California, 1989 to 2010. |
Q43931355 | Folic acid fortification and the birth prevalence of congenital heart defect cases in Alberta, Canada |
Q43704917 | Folic acid fortification: informed mothers, healthy babies |
Q34281640 | Folic acid in early pregnancy: a public health success story |
Q46943105 | Folic acid intake before and after mandatory fortification: a population-based study in São Paulo, Brazil |
Q40540531 | Folic acid knowledge and use among relatives in Irish families with neural tube defects: an intervention study |
Q33754493 | Folic acid to reduce neonatal mortality from neural tube disorders |
Q34421744 | Folic acid: are current fortification levels adequate? |
Q30252188 | Food Fortification and Supplement Use-Are There Health Implications? |
Q37005664 | Food fortification and decline in the prevalence of neural tube defects: does public intervention reduce the socioeconomic gap in prevalence? |
Q73398785 | Food fortification with folic acid and twinning among California infants |
Q84381046 | Fortification of corn masa flour with folic acid in the United States |
Q28364772 | Fortification of flour with folic acid |
Q24185965 | Fortification of wheat and maize flour with folic acid for population health outcomes |
Q34754422 | Fortification strategies to meet micronutrient needs: successes and failures |
Q44087473 | Four years after enhanced folic acid fortification of the Canadian food supply--how are we doing? |
Q37419974 | Gender-specific psychosocial impact of living with epilepsy |
Q33647210 | Genetic and epigenetic contributions to human nutrition and health: managing genome-diet interactions |
Q33732467 | Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women. |
Q37465331 | Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida |
Q38734243 | Genetic polymorphisms and folate status. |
Q40783158 | Genetic significance of muscle segment homeo box1 gene in South Indian population for cleft lip and palate |
Q38135224 | Genetic studies of myelomeningocele |
Q28395472 | Genetic studies of the cystathionine beta-synthase gene and myelomeningocele |
Q66476558 | Genetic variation in biotransformation enzymes, air pollution exposures, and risk of spina bifida |
Q34111801 | Genetic variations in the GLUT3 gene associated with myelomeningocele |
Q54908931 | Genomic approaches to the assessment of human spina bifida risk. |
Q52146907 | Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis. |
Q26781313 | Hen Egg as an Antioxidant Food Commodity: A Review |
Q50341318 | High Gestational Folic Acid Supplementation Alters Expression of Imprinted and Candidate Autism Susceptibility Genes in a sex-Specific Manner in Mouse Offspring |
Q92797172 | High doses of folic acid induce a pseudo-methylenetetrahydrofolate syndrome |
Q44947714 | High rates of neural tube defects in Ukraine |
Q36188570 | High-dose folic acid supplementation alters the human sperm methylome and is influenced by the MTHFR C677T polymorphism |
Q30855219 | High-dose maternal folic acid supplementation before conception impairs reversal learning in offspring mice |
Q40743625 | Homocysteinemia is Associated with a Lower Degree of PBMC LINE-1 Methylation and a Higher Risk of CIN 2C in the U.S. Post-Folic Acid Fortification Era. |
Q35866246 | Hospital use, associated costs, and payer status for infants born with spina bifida |
Q48206331 | Hydrocephalus in children born in 1999-2002: epidemiology, outcome and ophthalmological findings |
Q42995756 | Impact of a stage-tailored, web-based intervention on folic acid-containing multivitamin use by college women |
Q34291579 | Impact of folic acid fortification of flour on neural tube defects: a systematic review |
Q43867317 | Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease |
Q43914415 | Improper supplementation habits of folic acid intake by Hungarian pregnant women: improper recommendations |
Q35990793 | Improved survival among children with spina bifida in the United States |
Q37986405 | In utero intervention for urologic diseases |
Q33895316 | Incidence of open neural tube defects in Nova Scotia after folic acid fortification. |
Q35967043 | Increased prevalence of some birth defects in Korea, 2009-2010. |
Q43759681 | Increasing evidence in favour of mandatory fortification with folic acid |
Q34736750 | Inertia on folic acid fortification: public health malpractice |
Q37206341 | Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status |
Q33930503 | International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? |
Q37288877 | Invited commentary: Preventing neural tube defects and more via food fortification? |
Q64127925 | Iron and zinc deficiencies in China: what is a feasible and cost-effective strategy? |
Q37611371 | Iron, folate and vitamin B12 levels in first trimester pregnancies in the Southwest region of Turkey |
Q37109633 | Is it time for vitamin B-12 fortification? What are the questions? |
Q35614686 | Is there more to folates than neural-tube defects? |
Q88009760 | Knowledge and Use of Folic Acid among Women Attending the high-Risk Prenatal Clinics at the Adults University Hospital in Puerto Rico |
Q58051381 | L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men |
Q61948312 | Large-Scale Food Fortification and Biofortification in Low- and Middle-Income Countries: A Review of Programs, Trends, Challenges, and Evidence Gaps |
Q24800740 | Law as a tool for preventing chronic diseases: expanding the range of effective public health strategies |
Q46526275 | Laying hens can convert high doses of folic acid added to the feed into natural folates in eggs providing a novel source of food folate |
Q85166451 | Liquid chromatography/mass spectrometry compatible approaches for the quantitation of folic acid in fortified juices and cereals using aqueous normal phase conditions |
Q36316162 | Long term trends in prevalence of neural tube defects in Europe: population based study |
Q35574228 | Long-latency deficiency disease: insights from calcium and vitamin D |
Q37877158 | MRI of closed spinal dysraphisms |
Q34378098 | MTHFR 677TT genotype and disease risk: is there a modulating role for B-vitamins? |
Q43267034 | Mandatory fortification of flour with folic acid to prevent neural-tube defects |
Q33901337 | Marginal folate inadequacy observed in a group of young children in Kwangju, Korea |
Q30061704 | Maternal and child health in Israel: building lives |
Q43285052 | Maternal caffeine consumption and risk of neural tube defects |
Q37017922 | Maternal diet supplementation with methyl donors and increased parity affect the incidence of craniofacial defects in the offspring of twisted gastrulation mutant mice. |
Q41073986 | Maternal folic acid supplementation trends 2009-2013. |
Q34327550 | Maternal obesity, folate intake, and neural tube defects in offspring |
Q30515879 | Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study |
Q39748857 | Maternal use of folic acid supplements and infant risk of neural tube defects in Norway 1999-2013. |
Q22336986 | Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification |
Q34363501 | Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children's Oncology Group |
Q44385332 | Measurements of sub-nanomolar concentrations of unmetabolised folic acid in serum |
Q33609457 | Mechanistic insights into folate supplementation from Crooked tail and other NTD-prone mutant mice |
Q37421199 | Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate |
Q33920719 | Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy |
Q24799429 | Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications |
Q35333340 | Microarray analysis reveals higher gestational folic Acid alters expression of genes in the cerebellum of mice offspring-a pilot study |
Q38001394 | Micronutrient deficiencies in inflammatory bowel disease: from A to zinc |
Q37153266 | Micronutrient fortification of food and its impact on woman and child health: a systematic review |
Q35968243 | Micronutrient fortification of foods--rationale, application and impact |
Q37725925 | Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I--Folate, Vitamin B12, Vitamin B6. |
Q50431565 | Milestones and controversies in maternal and child health: examining a brief history of micronutrient fortification in the US. |
Q28564329 | Moderately high folic acid supplementation exacerbates experimentally induced liver fibrosis in rats |
Q92327295 | Monitoring of the National Oil and Wheat Flour Fortification Program in Cameroon Using a Program Impact Pathway Approach |
Q44754584 | Mutations in Lyar and p53 are synergistically lethal in female mice |
Q46424754 | National food-fortification program with folic acid in Chile |
Q36782800 | Nationwide Trends and Variations in Urological Surgical Interventions and Renal Outcome in Patients with Spina Bifida |
Q62583226 | Natural Folates from Biofortified Tomato and Synthetic 5-methyl-tetrahydrofolate Display Equivalent Bioavailability in a Murine Model |
Q37623721 | Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: Reasons for Geographic and Racial Differences in Stroke study 2003-2007. |
Q44143233 | Neural tube defect-specific infant mortality in the United States |
Q24617456 | Neural tube defects and folate: case far from closed |
Q34240297 | Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism |
Q35116653 | Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States |
Q33895370 | Neural tube defects and periconceptional folic acid. |
Q35775893 | Neural tube defects in Latin America and the impact of fortification: a literature review |
Q47822638 | Neural tube defects in the Republic of Ireland in 2009-11. |
Q37236998 | Neural tube defects, folic acid and methylation |
Q34914300 | Neural tube defects: prevalence, etiology and prevention |
Q33620909 | Neural tube defects: recent advances, unsolved questions, and controversies |
Q46332837 | Neurological congenital malformations in a tertiary hospital in south Brazil |
Q24337874 | Nonsyndromic cleft lip and palate: CRISPLD genes and the folate gene pathway connection |
Q37204892 | Novel single nucleotide polymorphisms in the superoxide dismutase 1 and 2 genes among children with myelomeningocele |
Q37269818 | Nutritional control of epigenetic processes in yeast and human cells |
Q33621185 | Nutritional deficiencies in the pediatric age group in a multicultural developed country, Israel |
Q34756624 | Occurrence of low birthweight and preterm delivery among California infants before and after compulsory food fortification with folic acid |
Q45822890 | On the changing epidemiology of hydrocephalus |
Q44933198 | One-carbon metabolism-related gene polymorphisms and risk of breast cancer |
Q34221016 | Oral contraceptive use: impact on folate, vitamin B₆, and vitamin B₁₂ status |
Q38928818 | Pediatric SCI/D caregiver mental health and family dynamics in Colombia, South America. |
Q34158751 | Periconceptional bread intakes indicate New Zealand's proposed mandatory folic acid fortification program may be outdated: results from a postpartum survey. |
Q60045518 | Periconceptional folic acid supplementation and sex difference in prevention of neural tube defects and their subtypes in China: results from a large prospective cohort study |
Q44403303 | Periconceptional folic acid use and the prevalence of neural tube defects in The Netherlands |
Q21142704 | Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child |
Q34091191 | Periconceptional nutrient intakes and risks of neural tube defects in California |
Q44468328 | Periconceptional use of folic acid supplements in Oslo |
Q37701759 | Perinatal high methyl donor alters gene expression in IGF system in male offspring without altering DNA methylation |
Q84486755 | Plasma folate concentrations after a single dose ingestion of whole and skimmed folic acid fortified milks in healthy subjects |
Q39877945 | Plasma folate status and dietary folate intake among Chinese women of childbearing age. |
Q33915599 | Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease. |
Q36048129 | Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele |
Q36099211 | Population prevalence, attributable risk, and attributable risk percentage for high methylmalonic acid concentrations in the post-folic acid fortification period in the US. |
Q79182600 | Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification |
Q46915420 | Postprandial serum folic acid response to multiple doses of folic acid in fortified bread |
Q35212964 | Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States |
Q44279534 | Preconception and prenatal care |
Q27022466 | Preconception care: nutritional risks and interventions |
Q92165467 | Predicting potential to benefit from an iron intervention: a randomized controlled trial of double-fortified salt in female Indian tea pluckers |
Q80228431 | Preferential response of glutathione-related enzymes to folate-dependent changes in the redox state of rat liver |
Q79249789 | Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America |
Q34910353 | Prevalence and Correlates of Neural Tube Defect in South West Iran: Retrospective analysis. |
Q37093429 | Prevalence and determinants of preconception folic acid use: an Italian multicenter survey |
Q33930516 | Preventing neural tube defects in Europe: population based study |
Q36454010 | Prevention of neural tube defects by the fortification of flour with folic acid: a population-based retrospective study in Brazil. |
Q37085641 | Prevention of neural tube defects in the UK: a missed opportunity |
Q35107118 | Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women |
Q46938618 | Prevention of neural tube defects: prevalence of folic acid supplementation during pregnancy and associated factors in Pelotas, Rio Grande do Sul State, Brazil |
Q44707196 | Primary prevention of neural tube defects |
Q36470903 | Primary prevention of neural tube defects in Brazil: insights into anencephaly |
Q83867102 | Primary prevention of neural tube defects with folate in Western Australia: the value of the Western Australian Birth Defects Registry |
Q33949484 | Primary prevention of neural-tube defects and some other congenital abnormalities by folic acid and multivitamins: history, missed opportunity and tasks |
Q38162276 | Professor John Scott, folate and neural tube defects |
Q28363001 | Public health 101 for informaticians |
Q36098214 | Public health aspects of food fortification: a question of balance |
Q49954506 | Public health failure in the prevention of neural tube defects: time to abandon the tolerable upper intake level of folate |
Q37246164 | Public health significance of supplementation or fortification of grain products with folic acid |
Q34469951 | Quantifying the effect of folic acid |
Q44507142 | Racial differences in leading causes of infant death in the United States |
Q36298328 | Research goals for folate and related B vitamin in Europe. |
Q41467593 | Risk analysis applied to food fortification |
Q36552218 | Risk factors associated with birth defects at a tertiary care center in Pakistan |
Q37105836 | Risk factors for neural tube defects in Riyadh City, Saudi Arabia: Case-control study |
Q35579910 | Role of Folate in Colon Cancer Development and Progression |
Q47155134 | Scientific Opinion on Dietary Reference Values for folate |
Q36632129 | Serum folate and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism adjusted for folate intake |
Q37291392 | Session 1: Public health nutrition. Folic acid food fortification: the Irish experience |
Q58576790 | Sex differences in the prevalence of neural tube defects and preventive effects of folic acid (FA) supplementation among five counties in northern China: results from a population-based birth defect surveillance programme |
Q46248978 | Short-term evaluation of the impact of a fortified food aid program on the micronutrient nutritional status of Argentinian pregnant women |
Q35843632 | Should folic acid fortification be mandatory? Yes |
Q44405495 | Specific and sensitive quantification of folate vitamers in foods by stable isotope dilution assays using high-performance liquid chromatography-tandem mass spectrometry |
Q56168697 | Spina Bifida: Genes, Brain, and Development |
Q57664975 | Spinal dysraphism at the Syrian Neolithic site of Dja’de el-Mughara |
Q44833873 | Stroke, Cognitive Decline and Vascular Dementia: The Silent Epidemic of the 21st Century |
Q52109611 | Survival of infants diagnosed with encephalocele in Atlanta, 1979-98. |
Q37208056 | Syndromes, disorders and maternal risk factors associated with neural tube defects (IV). |
Q35127991 | Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established |
Q44476013 | The (ir)relevance of framing nutrition education messages |
Q89336018 | The Decline in Vitamin Research Funding: A Missed Opportunity? |
Q37390954 | The association and significance of H3K27me3 and a folate metabolic gene ACat2 in neural tube defects |
Q42655647 | The association between major birth defects and preterm birth |
Q44287756 | The beneficial effect of folate-enriched egg on the folate and homocysteine levels in rats fed a folate- and choline-deficient diet |
Q36914843 | The continuing challenge of understanding, preventing, and treating neural tube defects. |
Q89999360 | The dynamic methylome of islets in health and disease |
Q36277582 | The fetal origins of the metabolic syndrome: can we intervene? |
Q38562244 | The global regulatory landscape regarding micronutrient fortification of condiments and seasonings |
Q35069434 | The history of preconception care: evolving guidelines and standards |
Q24317138 | The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs |
Q24534785 | The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter |
Q36472226 | The impact of prenatal diagnosis on neural tube defect (NTD) pregnancy versus birth incidence in British Columbia |
Q35309398 | The impact of spina bifida on caregivers |
Q37057724 | The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders |
Q36689210 | The origins of health and disease: the influence of maternal diseases and lifestyle during gestation |
Q57710801 | The physiological paradox: reframing the polypill as a vaccine for cardiovascular disease |
Q38134419 | The role of folic acid fortification in neural tube defects: a review |
Q33592297 | The sex-specific role of plasma folate in mediating the association of dietary quality with depressive symptoms |
Q34482845 | The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis |
Q37720914 | The urologist's role in the management of spina bifida: a continuum of care |
Q46666425 | Theory of planned behavior and multivitamin supplement use in Caucasian college females |
Q50503037 | Thermal oxidation studies on reduced folate, L-5-methyltetrahydrofolic acid (L-5-MTHF) and strategies for stabilization using food matrices. |
Q51652594 | Three novel missense mutations in the filamin B gene are associated with isolated congenital talipes equinovarus. |
Q34895640 | Too much folate: a risk factor for cancer and cardiovascular disease? |
Q51579528 | U.S. provider reported folic acid or multivitamin ordering for non-pregnant women of childbearing age: NAMCS and NHAMCS, 2005-2006. |
Q34884548 | Understanding nutritional epidemiology and its role in policy |
Q97538254 | Understanding the mothers of children with Spina Bifida and Hydrocephalus in Tanzania |
Q57710612 | Use of FAO food balance sheets to estimate the potential ability of novel folate-enriched eggs to increase the folate supply in European Union countries |
Q44188141 | Use of folic acid supplements in the first trimester of pregnancy |
Q33899323 | Using current evidence in selecting antiepileptic drugs for use during pregnancy |
Q39346669 | Using latent class cluster analysis to screen high risk clusters of birth defects between 2009 and 2013 in Northwest China |
Q37535390 | Validation of Folate-Enriched Eggs as a Functional Food for Improving Folate Intake in Consumers |
Q37420512 | Vitamin B(12) and folic acid imbalance modifies NK cytotoxicity, lymphocytes B and lymphoprolipheration in aged rats |
Q37235374 | Vitamin B(12) metabolism during pregnancy and in embryonic mouse models |
Q37019073 | Vitamins in aging, health, and longevity |
Q43653559 | Wheat rolls fortified with microencapsulated L-5-methyltetrahydrofolic acid or equimolar folic acid increase blood folate concentrations to a similar extent in healthy men and women |
Q47845410 | Which information on women's issues in epilepsy does a community pharmacist need to know? A Delphi consensus study |
Q36287145 | Women and epilepsy. |
Q50541620 | Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. |
Q38124724 | You are what you eat, and so are your children: the impact of micronutrients on the epigenetic programming of offspring |
Q46693864 | [6S]5-methyltetrahydrofolate or folic acid supplementation and absorption and initial elimination of folate in young and middle-aged adults |
Search more.